Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

December 30, 2030

Study Completion Date

June 30, 2031

Conditions
Ovarian Cancer
Interventions
OTHER

Cryopreservation of gonadal tissue

Patients at risk for primary gonadal tumors will undergo unilateral or bilateral gonadectomy for clinical purposes as a standard of care, and a portion of the surgically removed tissue will be cryopreserved for fertility preservation. The pathologist will assess the tissue using sterile technique and every other section will undergo histologic analysis, including evaluation for the presence of tumor or viable germ cell elements. The sections of the tissue for fertility preservation will be refrigerated and held until a final diagnosis is made on the tissue sections that are being processed for histologic analysis. If no tumor is identified and viable germ cell elements are identified, the tissue sections allotted for preservation will be sent in holding media for processing and cryopreservation.

Trial Locations (1)

80045

RECRUITING

University of Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER